ALMR NASDAQ
Alamar Biosciences, Inc.
1W: -10.7%
1M: -6.8%
YTD: -6.8%
$20.51
-0.35 (-1.68%)
Weekly Expected Move ±8.5%
$18
$20
$22
$23
$25
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider+$8.0M
Congress—
ETF Holdings—
Key Statistics
Market Cap$192.3M
52W Range20.4-27.2
Volume138,766
Avg Volume526,627
Beta0.00
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJustin J. McAnear
Employees222
SectorHealthcare
IndustryBiotechnology
IPO Date2026-04-17
Websitealamarbio.com
47071 Bayside Parkway
Fremont, CA 94538
US
Fremont, CA 94538
US
(510) 626-9888
About Alamar Biosciences, Inc.
Alamar Biosciences is a commercial-stage proteomics company focused on ultra-sensitive, multiplexed protein detection for research and future clinical applications. Its platform combines proprietary instruments, consumables, and software to provide an end-to-end system for measuring multiple low-abundance proteins across research and potential clinical applications.
Latest News
Alamar Biosciences, Inc. GAAP EPS of -$1.74, revenue of $26M
Alamar Biosciences Reports First Quarter 2026 Financial Results
Alamar Biosciences Reports First Quarter 2026 Financial Results
Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference
Alamar Biosciences to Report First Quarter 2026 Financial Results on May 8, 2026
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Qiming Corporate GP | C-Conversion | 6,881,410 | — | 2026-04-20 |
| Qiming Corporate GP | J-Other | 6,881,410 | — | 2026-04-20 |
| Qiming Corporate GP | J-Other | 1,922,329 | — | 2026-04-20 |
| Qiming Corporate GP | C-Conversion | 1,922,329 | — | 2026-04-20 |
| Qiming Corporate GP | J-Other | 1,605,645 | — | 2026-04-20 |